A short social post says the drugs cut appetite and improve blood sugar but carry real side effects, linking out for more detail.
Recap by typeshit. Post by CPOHealth on X.
Lilly's retatrutide is still in development with no FDA approval, yet CBS investigators found vials labeled 'reta' easy to buy across the internet and in shops.
A systematic review cited by Dr. Axe found human safety data on BPC-157 comes from just 30 people, a thin base for a widely used peptide.
A short post from the endocrinologist pushing back on headlines tying the eye condition to GLP-1 drugs, urging people to look at the data.
A brief post notes growing concern over reports of serious eye problems in people taking Ozempic and similar drugs, while research into the link continues.
The claim credits GLP-1 drugs' effects on insulin sensitivity and inflammation for changes in dermatologic conditions. No study is cited.
12:10
InforMed breaks down the head-to-head question between Novo's CagriSema and tirzepatide using the 84-week trial results.
Loading…